Therapeutic Observation of Application at Shenque (CV8) for Primary Dysmenorrhea Due to Blood Stagnation
10.13460/j.issn.1005-0957.2017.02.0162
- VernacularTitle:神阙敷贴法治疗血瘀型原发性痛经疗效观察
- Author:
Jiao YANG
;
Xiquan GUO
- Keywords:
Application therapy;
Point;
Shenque (CV8);
Dysmenorrhea;
Blood stasis;
Dysmenorrhea scoring
- From:
Shanghai Journal of Acupuncture and Moxibustion
2017;36(2):162-166
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of application at Shenque (CV8) in treating primary dysmenorrhea due to blood stagnation.Method Sixty patients with primary dysmenorrhea due to blood stagnation were enrolled and randomized into a treatment group and a control group to receive the corresponding intervention, started 3 d prior to menstruation. The treatment group was intervened by application at Shenque with Chinese herbal medicinewhile the control group was by orally taking Ibuprofen sustained release capsules, successively for 3 menstrual cycles. The pre-treatment, short-term and follow-up dysmenorrhea scores and traditional Chinese medicine symptom and sign scores for blood stagnation were recorded, and the clinical efficacies of the two groups were observed.Result The short-term total effective rate was 93.3% in the treatment group, slightly lower than 96.7% in the control group, while the long-term therapeutic efficacy in the treatment group (93.3%) was obviously higher than that in the control group (50.0%). The changes in the symptom and sign scores for blood stagnation in the treatment group were more significantthan those in the control group, especially in the scores of menstruation amount, blocked menstrual flow, color of menstrual blood and blood clots (P<0.01). No adverse events occurred during the whole study. Conclusion Application at Shenque can effectively release menstrual pain and improve the symptoms of dysmenorrhea due to blood stagnation.